Teva Pharmaceutical Industries
TEVA
#690
Rank
$34.18 B
Marketcap
$29.80
Share price
4.34%
Change (1 day)
71.76%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - Cash on Hand

Cash on Hand as of September 2025 : $2.20 Billion USD

According to Teva Pharmaceutical Industries's latest financial reports the company has $2.20 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Teva Pharmaceutical Industries - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$3.30 B2.29%
2023-12-31$3.22 B15.17%
2022-12-31$2.80 B29.38%
2021-12-31$2.16 B-0.55%
2020-12-31$2.17 B10.23%
2019-12-31$1.97 B10.83%
2018-12-31$1.78 B85.05%
2017-12-31$0.96 B-2.53%
2016-12-31$0.98 B-85.78%
2015-12-31$6.94 B212.04%
2014-12-31$2.22 B114.45%
2013-12-31$1.03 B-63.95%
2012-12-31$2.87 B162.68%
2011-12-31$1.09 B-14.64%
2010-12-31$1.28 B-42.88%
2009-12-31$2.24 B17.88%
2008-12-31$1.90 B-33.67%
2007-12-31$2.87 B40.66%
2006-12-31$2.04 B-7.59%
2005-12-31$2.21 B112.49%
2004-12-31$1.04 B-24.53%
2003-12-31$1.37 B31.92%
2002-12-31$1.04 B32.33%
2001-12-31$0.79 B86.12%
2000-12-31$0.42 B349.7%
1999-12-31$94.4 M91.88%
1998-12-31$49.2 M-16.04%
1997-12-31$58.6 M-15.32%
1996-12-31$69.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
$9.75 B 342.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
$10.45 B 374.44%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$4.44 B 101.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$14.98 B 580.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$18.21 B 726.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$0.78 B-64.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
AstraZeneca
AZN
$8.18 B 271.40%๐Ÿ‡ฌ๐Ÿ‡ง UK